Valuation : Rani Therapeutics Holdings, Inc.

Market Cap 99.88M 85.89M 80.79M 73.75M 138M 9.45B 138M 958M 370M 4.84B 375M 367M 15.41B P/E 2026 *
-4.99x
P/E 2027 * -4.55x
Enterprise Value 99.88M 85.89M 80.79M 73.75M 138M 9.45B 138M 958M 370M 4.84B 375M 367M 15.41B EV / Sales 2026 *
16x
EV / Sales 2027 * 15.1x
Free-Float
-
Yield 2026 *
-
Yield 2027 * -
1 day+1.54%
1 week+3.01%
Current month+1.35%
1 month+10.78%
3 months+4.32%
6 months-33.44%
Current year-35.90%
1 week 0.84
Extreme 0.837
0.9
1 month 0.75
Extreme 0.752
0.93
Current year 0.61
Extreme 0.6126
1.54
1 year 0.45
Extreme 0.4453
3.87
3 years 0.39
Extreme 0.387
8.75
5 years 0.39
Extreme 0.387
36.27
10 years 0.39
Extreme 0.387
36.27
Manager TitleAgeSince
Chief Executive Officer 45 01/06/2021
Director of Finance/CFO 46 29/06/2026
Chief Tech/Sci/R&D Officer 42 01/01/2022
Director TitleAgeSince
Chairman 69 01/06/2021
Director/Board Member 80 01/09/2018
Director/Board Member 69 06/04/2021
Date Insider Type Main position Quantity % Market Cap. Importance
8/3/26 A Free

Director

247,200 0.2479%
8/1/26 A Other

Director

12,500 0.0125%
7/21/26 A Buy

Founder

36,000 0.0361%
Change 5-day change 1-year change 3-year change Capi.($)
+1.54%+3.01%+72.30%-77.81% 99.88M
-0.38%-2.64%+42.69%+99.03% 67.98B
-2.71%-0.71%+34.08%+81.43% 64.94B
-0.31%+6.54%-12.96%+377.83% 27.58B
+0.86%+1.65%-7.74%-13.58% 26.06B
-1.42%-4.28%+31.24%+13.27% 25.74B
-1.11%+0.90%+23.12%-18.50% 20.09B
+1.15%-14.24%+219.82%+381.14% 17.16B
+0.20%-4.68%-6.41%+560.92% 14.92B
-0.20%+8.37%+55.78%+165.57% 14.62B
Average -0.24%+1.24%+45.19%+156.93% 27.92B
Weighted average by Cap. -0.81%+0.59%+36.98%+141.04%

Financials

2026 *2027 *
Net sales 6.26M 5.38M 5.06M 4.62M 8.64M 592M 8.67M 60.01M 23.2M 303M 23.5M 22.99M 965M 6.63M 5.7M 5.36M 4.9M 9.16M 627M 9.19M 63.61M 24.59M 321M 24.91M 24.36M 1.02B
Net income -31.46M -27.06M -25.45M -23.23M -43.44M -2.98B -43.59M -302M -117M -1.52B -118M -116M -4.85B -36.73M -31.59M -29.71M -27.12M -50.72M -3.47B -50.88M -352M -136M -1.78B -138M -135M -5.67B
Net Debt - -
Logo Rani Therapeutics Holdings, Inc.
Rani Therapeutics Holdings, Inc. is a clinical-stage biotherapeutics company focused on advancing technologies to enable the development of orally administered biologics and drugs. The Company has developed the RaniPill capsule, which is a proprietary and patented platform technology, intended to replace subcutaneous injection or intravenous infusion of biologics and drugs with oral dosing. The RaniPill capsule is designed to deliver a variety of drug substances, including antibodies, proteins, peptides, and oligonucleotides. It has two configurations of the platform: the RaniPill GO and the RaniPill HC. The RaniPill GO is designed to deliver up to a 3 mg dose of drug in microtablet form with high bioavailability. It is also developing a high-capacity version of the RaniPill capsule known as the RaniPill HC. Its product candidate pipeline includes obesity programs (RT-114 and RT-116), immunology programs (RT-105 and RT-111) and endocrinology programs (RT-102 and RT-110).
Employees
70
Date Price Change Volume
04/09/26 $0.8653 +1.54% 381,105
03/09/26 $0.8522 -0.68% 392,227
02/09/26 $0.8580 -0.75% 426,670
01/09/26 $0.8645 +1.25% 1,155,898
31/08/26 $0.8538 +1.64% 382,589
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
0.8653USD
Average target price
7.200USD
Spread / Average Target
+732.08%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. RANI Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!